Schaeffer's Top Stock Picks for '25

Mattel, Brinker International, Vertex Downgraded

Analysts downwardly revised their ratings and price targets on Fisher-Price parent Mattel, Inc. (MAT), restaurant stock Brinker International, Inc. (EAT), and biotech Vertex Pharmaceuticals Incorporated (VRTX)

Jan 26, 2017 at 11:04 AM
facebook X logo linkedin


Analysts are weighing in on Fisher-Price parent Mattel, Inc. (NASDAQ:MAT), restaurant stock Brinker International, Inc. (NYSE:EAT), and biotech Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Here's a quick look at today's bearish brokerage notes on MAT, EAT, and VRTX.

Mattel Cut to "Neutral" at MKM Partners

MAT is down 14.3% at $27.05, after the company reported an earnings miss, with the results pressured by a global decline in Fisher-Price and Barbie sales. MKM Partners downgraded MAT to "neutral" from "buy," and joined a number of other brokerage firms in cutting its price target. Today's drop puts MAT down nearly 21% since its mid-August peak near $34.25. In the option pits, near-term traders are more call-skewed now than they've been at any other point during the past year, with MAT's Schaeffer's put/call open interest ratio (SOIR) of 0.24 sitting at an annual low.

Post-Earnings Analyst Backlash for Brinker

After plunging 6.2% yesterday following an earnings miss, EAT is up 1.3% at $44.83 -- which isn't too surprising considering the stock's 14-day Relative Strength Index (RSI) settled at 23, well into oversold territory. Today's bounce comes despite a round of bearish brokerage attention, with EAT receiving no fewer than nine price-target cuts, including one to $43 from $56 at Canaccord Genuity, which said "top-line challenges are likely to persist." Brinker International, Inc.'s withstanding trend has been to the downside, though, with the stock down nearly 20% since touching an annual high of $55.84 in November.

Vertex Attracts Mixed Analyst Attention Post-Earnings

VRTX is down 0.8% at $84.49, after Jefferies and Goldman Sachs cut their respective price targets to $100 and $78, following the company's earnings report and full-year guidance. Leerink, meanwhile, hiked its price target to $115. VRTX shares are staring up at their 200-day moving average, and have a year-over-year loss of 8.5%. Option traders have been buying to open calls over puts at a rapid-fire rate in recent months. VRTX's 50-day call/put volume ratio of 3.84 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is ranked just 2 percentage points from an annual peak.

Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap
 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?